Scope of scientific reflections expands as ANGANY advances clinical development of First-in-Class biologics ANGANY recently hosted members of its Scientific Advisory Board in beautiful Quebec City. This was the company’s…
Read More
News
Quebec City, Canada and Val de Reuil, France, November 22nd, 2023 – ANGANY inc. announces that it has received a unanimous recommendation from its Safety Review Committee to press ahead with its First-in-Human…
ANGANY expands and redefines its executive team to better manage upcoming development stages. Québec, Canada, November 2nd, 2023 – ANGANY announces the appointment of Christine Guillen, PharmD, as Chief Executive…
The Royal Brompton Hospital, in London, begins Clinical Trial of Angany’s Vaccine Candidate to treat Cat Allergy. Quebec City, Canada, October 3, 2023 – Angany Inc., announces that it has received clearance…
Montréal, QC, July 4, 2023. Louis-Philippe Vézina, CEO of ANGANY, and Réjean Lapointe, principal scientist and head of cancer research at the CHUM Research Centre (CRCHUM), have announced a partnership to…
By Dr Guy Tropper, Executive Vice President, Co-Founder Biologics, a class of medications made of complex proteins have come to widespread use in the past two decades, changing the lives…
There is currently no cure for allergies. Over-the-counter and prescription medications relieve patients of symptoms, but don’t prevent allergy from progressing. The only disease-modifying treatment against allergy is desensitization, a…
Since the early nineties several approaches have been tested to develop safe and effective allergen immunotherapy (AIT) for the treatment of peanut allergy, starting with subcutaneous AIT with aqueous extract,…
Allergen immunotherapy (AIT) still remains the only disease- modifying treatment for immunoglobulin E (IgE)-mediated allergies with proven sustained efficacy upon discontinuation of the treatment, provided it is administered regularly for…
San Diego, June 15th. Canadian biotechnology company ANGANY (www.ANGANY.com) is presenting its immunotherapy platform at BIO International Convention, a critical rendez-vous for the global pharmaceutical industry which takes place in…